Saturday, July 11, 2026

pharma · Heart Valve Diseases · Angina, Stable

Beijing Anzhen Hospital

Beijing Anzhen Hospital clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
1
Patents
0
Intelligence · Clinical Programs

Beijing Anzhen Hospital projects

2 ClinicalTrials.gov programs sponsored by Beijing Anzhen Hospital.

Beijing Anzhen Hospital has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CYP2C19 genotype testing

    Beijing Anzhen Hospital

    Angina, Stable

    gene therapy active

    1 trial
  2. Corticosteroid

    Beijing Anzhen Hospital

    Heart Valve Diseases

    small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Beijing Anzhen Hospital have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.